Page 11 - Dr Reddys
Dr Reddy's halts worldwide supply of Ranitidine drug after probe by USFDA
Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach
 "Dr Reddy's halts worldwide supply of Ranitidine drug after probe by USFDA")
Regulatory worries, price erosion may pull down Dr Reddy's US revenues
Repeat observations for an approved facility are an indication of consistent regulatory challenges for the company, says an analyst with a foreign brokerage
 "Regulatory worries, price erosion may pull down Dr Reddy's US revenues")
Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing
A CRL is issued when the FDA decides not to approve new or generic drug application for marketing in its present form
 "Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing")
Dr Reddy's launches insomnia treatment tablets in US after FDA approval
The product is a generic version of Takeda Pharmaceutical Company's Rozerem tablets in the same strength
Dr Reddy's closes sale of US, select territory rights for neurology drugs
Under the agreement, Dr Reddy's sold its US and select territory rights for Zembrace Symtouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg
 "Dr Reddy's closes sale of US, select territory rights for neurology drugs")
Dr Reddy's Laboratories unveils generic version of Allegra-D in US
Allegra-D 12 HR is a trademark of Aventisub II Inc
 "Dr Reddy's Laboratories unveils generic version of Allegra-D in US")
Dr Reddy's Laboratories launches generic anti-cancer drug in US market
Gleevec and its generic equivalents saw sales of approximately $868 mn in the US for the last twelve months ending in July 2018
 "Dr Reddy's Laboratories launches generic anti-cancer drug in US market")